P2B001/003 — Falls Church, Virginia

P2B001/003 is a clinical research site located in Falls Church, Virginia, United States 22042.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

P2B001/003 has participated in 1 clinical trials.

Therapeutic areas: Parkinson Disease, Early Parkinson's Disease.

Sponsors: Pharma Two B Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Falls Church

Browse all research sites in Virginia · View every site in Falls Church

• Inova Fairfax Hospitals
• Inova Health System Foundation / Inova Fairfax Hospital
• Institute of Resch & Educ Inova Fairfax Hospital
• Inova Fairfax Hospital/Inova Heart and Vascular Institute
• Inova Medical Group - Fairfax Hospital
• Inova Fairfax Hospital Department of Surgery
• INOVA Hospital
• Inova Fairfax Hospital/ Heart and Vascular Institute Advanced Lung Disease and Transplant Center
• Inova Fairfax Hospital
• Innova Fairfax Hospital
• Inova Health Systems; Inova Fairfax Hospital
• Virginia Hospital Center - Arlington

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for P2B001/003?

P2B001/003 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has P2B001/003 conducted?

P2B001/003 has 1 clinical trials on record. Their work covers Parkinson Disease, Early Parkinson's Disease.

Is P2B001/003 accredited by Crixeo Clinical Trials?

P2B001/003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about P2B001/003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.